These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12757772)

  • 21. Platelet hyporeactivity in young infants during cardiopulmonary bypass.
    Ichinose F; Uezono S; Muto R; Uchida H; Hatori F; Terui K; Niimi Y; Goto T; Nakata Y; Morita S
    Anesth Analg; 1999 Feb; 88(2):258-62. PubMed ID: 9972737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet function in cardiac surgery: influence of temperature and aprotinin.
    Boldt J; Knothe C; Zickmann B; Bill S; Dapper F; Hempelmann G
    Ann Thorac Surg; 1993 Mar; 55(3):652-8. PubMed ID: 7680852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding.
    Uthoff K; Zehr KJ; Geerling R; Herskowitz A; Cameron DE; Reitz BA
    Circulation; 1994 Nov; 90(5 Pt 2):II269-74. PubMed ID: 7955264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent effect of aprotinin on aggravated pro-inflammatory cytokines in patients with pulmonary hypertension following cardiopulmonary bypass.
    Lei Y; Haider HKh; Chusnsheng W; Zhiqiang C; Hao C; Kejian H; Qiang Z
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):343-8. PubMed ID: 14618096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin receptor-related hemostatic defect after cardiopulmonary bypass.
    Ferraris VA; Ferraris SP; Reich H; Rodriguez E; Huang M; Gupta A; Bennett JA; Andersen TT; Fenton JW
    Semin Thromb Hemost; 1996; 22(4):351-6. PubMed ID: 8944421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.
    van Oeveren W; Jansen NJ; Bidstrup BP; Royston D; Westaby S; Neuhof H; Wildevuur CR
    Ann Thorac Surg; 1987 Dec; 44(6):640-5. PubMed ID: 2446574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of controlled aprotinin administration through cardiotomy suction during cardiopulmonary bypass.
    Liu JL; Stammers AH; Zheng H; Mills NJ; Nichols JD; Kmiecik SA; Kohtz RJ; Petterson CM
    J Extra Corpor Technol; 2002 Sep; 34(3):203-8. PubMed ID: 12395967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass.
    Shigeta O; Kojima H; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
    Circulation; 1997 Jul; 96(2):569-74. PubMed ID: 9244227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aprotinin counteracts heparin-induced inhibition of platelet contractile force.
    Carr ME; Carr SL; Roa V; McCardell KA; Greilich PE
    Thromb Res; 2002 Nov; 108(2-3):161-8. PubMed ID: 12590953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating adhesion molecules in cardiac operations: influence of high-dose aprotinin.
    Boldt J; Osmer C; Schindler E; Linke LC; Stertmann WA; Hempelmann G
    Ann Thorac Surg; 1995 Jan; 59(1):100-5. PubMed ID: 7529482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprotinin attenuates the elevation of pulmonary vascular resistance after cardiopulmonary bypass.
    Yun TJ; Rho JR
    J Korean Med Sci; 2006 Feb; 21(1):25-9. PubMed ID: 16479060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding complications associated with cardiopulmonary bypass.
    Woodman RC; Harker LA
    Blood; 1990 Nov; 76(9):1680-97. PubMed ID: 2224118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit.
    Lowson SM; Hassan HM; Rich GF
    Anesth Analg; 1999 Dec; 89(6):1360-5. PubMed ID: 10589608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
    Spannagl M; Dooijewaard G; Dietrich W; Kluft C
    Thromb Haemost; 1995 May; 73(5):825-8. PubMed ID: 7482410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin.
    Mannucci L; Gerometta PS; Mussoni L; Antona C; Parolari A; Salvi L; Biglioli P; Tremoli E
    Thromb Haemost; 1995 Mar; 73(3):356-61. PubMed ID: 7545317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
    Huang H; Ding W; Su Z; Zhang W
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement.
    Machin D; Devine P
    J Extra Corpor Technol; 2005 Sep; 37(3):265-71. PubMed ID: 16350378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.